{"id":841707,"date":"2025-04-24T13:17:50","date_gmt":"2025-04-24T17:17:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"modified":"2025-04-24T13:17:50","modified_gmt":"2025-04-24T17:17:50","slug":"investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","title":{"rendered":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO, April  24, 2025  (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) (\u201cTreace Medical\u201d or the \u201cCompany\u201d) securities between May 8, 2023 and May 7, 2024 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d).<\/p>\n<p align=\"justify\">Treace Medical investors have until June 10, 2025 to seek appointment as lead plaintiff of the Treace Medical class action lawsuit.<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>If you purchased or acquired Treace Medical securities between May 8, 2023 and May 7, 2024, and suffered substantial losses<\/em><br \/>\n        <\/strong>, and you wish to obtain additional information or serve as lead plaintiff in this lawsuit, you may <strong><em>submit your information and contact us here: <\/em><\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XGHRzv0Q7TyeWrKg3K7tbP_JmDkRJIM_bui2vOwkAx2lY31WZO834u_Vgw-8YhhddmsNmpwFhQySy4kfoI2ll-1rc_NYHfwuskZh3qPPbVqaCRhCgWQDaDcbSQ_-QIpTEoZNpewhjOSlsPhztYlcYqpPugPdZqZsAjOMZzvNL8o_-vK9aI4ZunEoJwwQbNrF\" rel=\"nofollow\" target=\"_blank\">https:\/\/dicellolevitt.com\/securities\/treace-medical\/<\/a>.<\/p>\n<p align=\"justify\">You can also contact DiCello Levitt attorneys Brian O\u2019Mara or Ruben Pe\u00f1a by calling (888) 287-9005 or emailing <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TrlmEH5EZCHC-iuJxShrbcqinBXbbu_G99jRhYGGnyK1dhAkfg1NNPlFGo0DuVHAFDHCxjWNaz7LMhqspO83ADqzDkxIbUCxj_ryTi7vz9weRkwkzBqO_d1EyMb1c1H-\" rel=\"nofollow\" target=\"_blank\">investors@dicellolevitt.com<\/a>. Those who inquire by email are encouraged to include their mailing address, telephone number, and the number of shares purchased.<\/p>\n<p align=\"justify\">No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice.<\/p>\n<p align=\"justify\">\n        <strong>Case Allegations<\/strong>\n      <\/p>\n<p align=\"justify\">Treace Medical is a medical technology company focused on advancing the standard of care for the surgical management of bunion and related midfoot deformities. The Company\u2019s primary product is the patented Lapiplasty\u00ae 3D Bunion Correction\u00ae System, a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint. Treace Medical sells these products to physicians, surgeons, hospitals, and ambulatory surgery centers in the United States.<\/p>\n<p align=\"justify\">The Treace Medical lawsuit alleges that Defendants made false or misleading statements concerning the Company\u2019s business, operations, and prospects. Specifically, Defendants failed to disclose that: (1) competition impacted the demand for and utilization of Treace Medical\u2019s primary product, the Lapiplasty\u00ae 3D Bunion Correction\u00ae System; and (2) as a result, Treace Medical\u2019s revenue declined and the Company needed to accelerate its plans to offer an alternative product to osteotomy (a surgical procedure involving the cutting and realigning of bone to improve its position or function).<\/p>\n<p align=\"justify\">The truth emerged on May 7, 2024, when Treace Medical issued a press release, announcing its financial results for its first quarter of 2024 and fiscal year 2024. During the associated earnings call, Defendants revealed the business impact the Company had suffered due to competitors\u2019 minimally invasive (\u201cMIS\u201d) osteotomy and \u201cknockoffs\u201d of its Lapiplasty\u00ae 3D Bunion Correction\u00ae System. In relevant part, Defendants stated that it has \u201c<strong><em>become clear that the market environment and competitive landscape is quickly evolving, . . . we\u2019re seeing increased use in surgeon adoption of MIS Osteotomy solutions. At the same time, we\u2019re facing even more competition from knockoffs of our Lapiplasty products. Both of these dynamics are creating incremental headwinds to our Lapiplasty growth.<\/em><\/strong>\u201d<\/p>\n<p align=\"justify\">On this news, the price of Treace Medical\u2019s stock price fell by $6.95 per share, or nearly 63%, to close at $4.17 per share on May 8, 2024.<\/p>\n<p align=\"justify\">\n        <strong>About DiCello Levitt<\/strong>\n      <\/p>\n<p align=\"justify\">At DiCello Levitt, we are dedicated to achieving justice for our clients through class action, business-to-business, public client, whistleblower, personal injury, civil and human rights, and mass tort litigation. Our lawyers are highly respected for their ability to litigate and win cases \u2013 whether by trial, settlement, or otherwise \u2013 for people who have suffered harm, global corporations that have sustained significant economic losses, and public clients seeking to protect their citizens\u2019 rights and interests. Every day, we put our reputations \u2013 and our capital \u2013 on the line for our clients.<\/p>\n<p align=\"justify\">DiCello Levitt has achieved top recognition as Plaintiffs Firm of the Year and Trial Innovation Firm of the Year by the <em>National Law Journal<\/em>, in addition to its top-tier <em>Chambers<\/em> and <em>Benchmark<\/em> ratings. The <em>New York Law Journal<\/em> also recently recognized DiCello Levitt as a Distinguished Leader in trial innovation. For more information about the Firm, including recent trial victories and case resolutions, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4MpLjYZdNkr1QbbuG4Ru6MgbCwnNGT6Xr0L2LEXK0-Cw_iZVuvIvKxMlcN2ogpBxuloEVZ0t57KYiG01T1Y6Lz-mb-8FT4t7F_8mqp8-Wjg=\" rel=\"nofollow\" target=\"_blank\">www.dicellolevitt.com<\/a>.<\/p>\n<p align=\"justify\">Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p align=\"justify\">\n        <strong>Media Contact<\/strong>\n      <\/p>\n<p align=\"justify\">Amy Coker<br \/>4747 Executive Drive, Suite 240<br \/>San Diego, CA 92121<br \/>619-963-2426<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TrlmEH5EZCHC-iuJxShrbcqinBXbbu_G99jRhYGGnyJlRTSWJPawEGlCg_c4KzLvGshaemZtXtLWlRXgn0GI-kx4y1Apsf8osIuKX6LxLLWJH-jM5PCaIpvn0vjso9Eh\" rel=\"nofollow\" target=\"_blank\">investors@dicellolevitt.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/M2UzNmY3OGEtNWIwZC00OWU5LWEzODMtODk1ZDFiMjI0ZDJjLTEyODY2MzItMjAyNS0wNC0yNC1lbg==\/tiny\/DiCello-Levitt-LLP.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) (\u201cTreace Medical\u201d or the \u201cCompany\u201d) securities between May 8, 2023 and May 7, 2024 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). Treace Medical investors have until June 10, 2025 to seek appointment as lead plaintiff of the Treace Medical class action lawsuit. If you purchased or acquired Treace Medical securities between May 8, 2023 and May 7, 2024, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-841707","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) (\u201cTreace Medical\u201d or the \u201cCompany\u201d) securities between May 8, 2023 and May 7, 2024 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). Treace Medical investors have until June 10, 2025 to seek appointment as lead plaintiff of the Treace Medical class action lawsuit. If you purchased or acquired Treace Medical securities between May 8, 2023 and May 7, 2024, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff &hellip; Continue reading &quot;INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-24T17:17:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\",\"datePublished\":\"2025-04-24T17:17:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"},\"wordCount\":707,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\",\"name\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\",\"datePublished\":\"2025-04-24T17:17:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","og_locale":"en_US","og_type":"article","og_title":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","og_description":"SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) &#8212; A class action lawsuit has been filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical Concepts, Inc. (NASDAQ: TMCI) (\u201cTreace Medical\u201d or the \u201cCompany\u201d) securities between May 8, 2023 and May 7, 2024 (the \u201cClass Period\u201d), charging the Company and certain senior executives with violations of the federal securities laws (collectively, \u201cDefendants\u201d). Treace Medical investors have until June 10, 2025 to seek appointment as lead plaintiff of the Treace Medical class action lawsuit. If you purchased or acquired Treace Medical securities between May 8, 2023 and May 7, 2024, and suffered substantial losses , and you wish to obtain additional information or serve as lead plaintiff &hellip; Continue reading \"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-24T17:17:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel","datePublished":"2025-04-24T17:17:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"},"wordCount":707,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/","name":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=","datePublished":"2025-04-24T17:17:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQzODUyOSM2OTA0MTQyIzIyNzUwODI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/investor-alert-shareholder-class-action-lawsuit-filed-against-treace-medical-concepts-inc-nasdaq-tmci-dicello-levitt-llp-encourages-investors-with-losses-to-discuss-their-options-with-counsel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/841707","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=841707"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/841707\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=841707"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=841707"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=841707"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}